Laércio Martins Rodrigues

🌎EFECTOS ADVERSOS🛡💉

Laércio Martins Rodrigues, falleció el 3 de agosto de 2021, fue diagnosticado con síndrome de Guillan Barre después de recibir la inyección C-19 de AstraZeneca, permaneció por un mes y medio en una UCI con ventilación mecánica y era tratado con inmunoglobulina, falleció después de sufrir un paro cardíaco.

Fuente: FACEBOOK

Fuente: FACEBOOK

Recopilación de casos que han presentado efectos adversos o muertes posteriores a la "inyección".
https://www.tg-me.com/sg/EFECTOS ADVERSOS/com.EFECTOSADVERSOS1

www.tg-me.com/sg/EFECTOS ADVERSOS/com.EFECTOSADVERSOS1/1844

19.6K viewsJul 21, 2022 at 16:56

tg-me.com/EFECTOSADVERSOS1/1844

Create: 2022-07-21
Last Update: 2025-06-03 00:50:26

BY 🌎EFECTOS ADVERSOS🛡💉

Share with your friend now:
tg-me.com/EFECTOSADVERSOS1/1844

EFECTOS ADVERSOS Telegram | DID YOU KNOW?

Spiking bond yields driving sharp losses in tech stocks

A spike in interest rates since the start of the year has accelerated a rotation out of high-growth technology stocks and into value stocks poised to benefit from a reopening of the economy. The Nasdaq has fallen more than 10% over the past month as the Dow has soared to record highs, with a spike in the 10-year US Treasury yield acting as the main catalyst. It recently surged to a cycle high of more than 1.60% after starting the year below 1%. But according to Jim Paulsen, the Leuthold Group's chief investment strategist, rising interest rates do not represent a long-term threat to the stock market. Paulsen expects the 10-year yield to cross 2% by the end of the year. A spike in interest rates and its impact on the stock market depends on the economic backdrop, according to Paulsen. Rising interest rates amid a strengthening economy "may prove no challenge at all for stocks," Paulsen said.

At a time when the Indian stock market is peaking and has rallied immensely compared to global markets, there are companies that have not performed in the last 10 years. These are definitely a minor portion of the market considering there are hundreds of stocks that have turned multibagger since 2020. What went wrong with these stocks? Reasons vary from corporate governance, sectoral weakness, company specific and so on. But the more important question is, are these stocks worth buying?